Once again taking the lead in cutting-edge medical research, STBTC and BioBridge Global will figure prominently in a case study that will be presented by the Harvard Business and Medical Schools at the Forum on Healthcare Innovation conference in April. A researcher from Harvard Business School will toured STBTC operations on Friday, Feb. 6, to gather information to write the study.
The road to Harvard began with STBTC’s participation in a pilot program by Bloodbuy, a Dallas-based health care technology company. It connects hospitals that need blood with the blood centers that have it via a cloud-based ordering system that enables blood supply-chain efficiency and pricing transparency. For more information about this study, click here.